{"id":10561,"date":"2026-03-12T09:49:59","date_gmt":"2026-03-12T13:49:59","guid":{"rendered":"https:\/\/www.rigicon.com\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/"},"modified":"2026-03-12T09:49:59","modified_gmt":"2026-03-12T13:49:59","slug":"first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br","status":"publish","type":"clinical-evidence","link":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/","title":{"rendered":"Primeiros resultados de seguran\u00e7a do esf\u00edncter urin\u00e1rio artificial Rigicon ContiClassic\u00ae"},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","tags":[],"ce_category":[233],"ce_product":[275],"class_list":["post-10561","clinical-evidence","type-clinical-evidence","status-publish","hentry","ce_category-publicacoes-revisadas-por-pares-pt-br","ce_product-conticlassic-pt-br"],"acf":{"ce_paper_title":"","ce_year":2023,"ce_journal":"IJIR: Your Sexual Medicine Journal","ce_doi":"https:\/\/doi.org\/10.1038\/s41443-023-00748-8","ce_summary":"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de revis\u00e3o de 6,9% e sobrevida do dispositivo de 93,2% em 12 meses.","ce_authors":"Steven K. Wilson, Eric Chung, Brian Langford, Ricardo Schlesinger, Orhan Koca, Abdulmuttalip Simsek, Cristian Persu, Tobias Pottek, John Mulcahy\r\n\r\n","ce_objective":"<p class=\"ai-optimize-8\">Relatar os primeiros resultados de seguran\u00e7a do esf\u00edncter urin\u00e1rio artificial Rigicon ContiClassic<sup>\u00ae<\/sup> no tratamento da incontin\u00eancia urin\u00e1ria de esfor\u00e7o masculina.<\/p>","ce_key_findings":"<p class=\"ai-optimize-9\">O estudo encontrou uma baixa taxa de revis\u00e3o de 6,9% sem infec\u00e7\u00f5es entre 116 pacientes implantados com o AUS ContiClassic<sup>\u00ae<\/sup>. A taxa de sobrevida de Kaplan-Meier em 12 meses foi de 93,2%. A maioria das revis\u00f5es foi devida a erros iatrog\u00eanicos como dimensionamento incorreto do cuff ou posicionamento inadequado do conector.<\/p>","ce_conclusion":"<p class=\"ai-optimize-10\">A experi\u00eancia cl\u00ednica inicial com o AUS Rigicon ContiClassic<sup>\u00ae<\/sup> mostra um perfil de seguran\u00e7a favor\u00e1vel com baixas taxas de complica\u00e7\u00e3o e revis\u00e3o. O dispositivo parece compar\u00e1vel em seguran\u00e7a a outros esf\u00edncteres do mercado.<\/p>","ce_clinical_relevance":"<p class=\"ai-optimize-11\">Os resultados apoiam o AUS Rigicon ContiClassic<sup>\u00ae<\/sup> como uma alternativa vi\u00e1vel aos esf\u00edncteres urin\u00e1rios artificiais existentes, potencialmente expandindo as op\u00e7\u00f5es de tratamento para incontin\u00eancia urin\u00e1ria de esfor\u00e7o masculina.<\/p>","ce_pdf":null,"ce_logos":null,"ce_featured":true,"ce_keywords":"ContiClassic\u00ae, esf\u00edncter urin\u00e1rio artificial, IUE masculina, incontin\u00eancia urin\u00e1ria, taxa de revis\u00e3o de AUS, Rigicon, cirurgia de contin\u00eancia, desfechos p\u00f3s-operat\u00f3rios"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Resultados de Seguran\u00e7a ContiClassic\u00ae AUS - Rigicon\u00ae<\/title>\n<meta name=\"description\" content=\"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Primeiros resultados de seguran\u00e7a do esf\u00edncter urin\u00e1rio artificial Rigicon ContiClassic\u00ae | Peer-Reviewed Research\" \/>\n<meta property=\"og:description\" content=\"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de revis\u00e3o de 6,9% e sobrevida do dispositivo de 93,2% em 12 meses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\\\/\",\"name\":\"Resultados de Seguran\u00e7a ContiClassic\u00ae AUS - Rigicon\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\"},\"datePublished\":\"2026-03-12T13:49:59+00:00\",\"description\":\"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evid\u00eancia Cl\u00ednica\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Primeiros resultados de seguran\u00e7a do esf\u00edncter urin\u00e1rio artificial Rigicon ContiClassic\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Resultados de Seguran\u00e7a ContiClassic\u00ae AUS - Rigicon\u00ae","description":"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/","og_locale":"pt_BR","og_type":"article","og_title":"Primeiros resultados de seguran\u00e7a do esf\u00edncter urin\u00e1rio artificial Rigicon ContiClassic\u00ae | Peer-Reviewed Research","og_description":"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de revis\u00e3o de 6,9% e sobrevida do dispositivo de 93,2% em 12 meses.","og_url":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/","url":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/","name":"Resultados de Seguran\u00e7a ContiClassic\u00ae AUS - Rigicon\u00ae","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#website"},"datePublished":"2026-03-12T13:49:59+00:00","description":"Este estudo avaliou os resultados iniciais de seguran\u00e7a do AUS Rigicon ContiClassic\u00ae em 116 pacientes. Os dados mostraram uma taxa de...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/first-safety-outcomes-for-rigicon-conticlassic-artificial-urinary-sphincter-pt-br\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rigicon.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Evid\u00eancia Cl\u00ednica","item":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/"},{"@type":"ListItem","position":3,"name":"Primeiros resultados de seguran\u00e7a do esf\u00edncter urin\u00e1rio artificial Rigicon ContiClassic\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/pt-br\/#website","url":"https:\/\/www.rigicon.com\/pt-br\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/pt-br\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/clinical-evidence\/10561","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/clinical-evidence"}],"about":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/types\/clinical-evidence"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media?parent=10561"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/tags?post=10561"},{"taxonomy":"ce_category","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/ce_category?post=10561"},{"taxonomy":"ce_product","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/ce_product?post=10561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}